Cargando…
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody
Sclerostin antibody (Scl-Ab) stimulates bone formation, which with long-term treatment, attenuates over time. The cellular and molecular mechanisms responsible for the attenuation of bone formation are not well understood, but in aged ovariectomized (OVX) rats, the reduction in vertebral cancellous...
Autores principales: | Boyce, Rogely Waite, Brown, Danielle, Felx, Melanie, Mellal, Nacera, Locher, Kathrin, Pyrah, Ian, Ominsky, Michael S., Taylor, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020110/ https://www.ncbi.nlm.nih.gov/pubmed/29955626 http://dx.doi.org/10.1016/j.bonr.2018.03.001 |
Ejemplares similares
-
Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats
por: Taylor, Scott, et al.
Publicado: (2018) -
Effects of anti-sclerostin antibody and running on bone remodeling and strength
por: Toumi, H., et al.
Publicado: (2015) -
A decrease in NAD(+) contributes to the loss of osteoprogenitors and bone mass with aging
por: Kim, Ha-Neui, et al.
Publicado: (2021) -
Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
por: Cardinal, Mickaël, et al.
Publicado: (2021) -
Nanotechnology for Stimulating Osteoprogenitor Differentiation
por: Ibrahim, A., et al.
Publicado: (2016)